C. Ustun

D. Weisdorf, E. Gluckman, V. Rocha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high‐risk myelodysplastic syndromes: Challenges and opportunities in implementation

D. Steensma, Bryce Waldman, A. Brunner, 2021, Cancer.

Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach

S. Yohe, C. Ustun, E. Warlick, 2017, BMC Clinical Pathology.

Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes.

M. Aljurf, R. Gale, K. Ballen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndromes Patients ≥70 Years Old

M. Arora, N. Bejanyan, T. DeFor, 2016 .

Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years.

D. Weisdorf, M. Arora, N. Bejanyan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Alan M. Miller, R. Vij, W. Wood, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dasatinib-induced immunosuppression and recurrent respiratory tract infections

P. Valent, C. Ustun, Jo-Anne H. Young, 2015, Leukemia & lymphoma.

Multiple Myeloma Associated with Lactic Acidosis

C. Ustun, P. Fall, A. Jillella, 2002, Leukemia & lymphoma.

Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome

C. Ustun, P. Ramalingam, Jennifer Jones-Crawford, 2008, Annals of Hematology.

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

H. Kantarjian, G. Garcia-Manero, J. Cortes, 2020, Leukemia & lymphoma.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

R. Gale, H. Khoury, U. Popat, 2018, Blood advances.

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

C. Ustun, D. DeRemer, Katerina Katsanevas, 2011, Cancer management and research.

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

M. Triggiani, A. Órfão, H. Kluin-Nelemans, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts

G. Nilsson, M. Triggiani, A. Órfão, 2020, Theranostics.

Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.

G. Nilsson, M. Triggiani, C. Bindslev‐Jensen, 2017, Cancer research.

The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis

W. Wood, D. Rizzieri, H. Lazarus, 2020 .

Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients

T. Pruett, S. Richmond, D. Weisdorf, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Amyloidosis, Evans syndrome and management options of lymphoplasmacytic lymphoma

C. Ustun, N. Savage, A. Jillella, 2009, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Investigational drugs targeting FLT3 for leukemia

K. Bhalla, C. Ustun, D. DeRemer, 2009, Expert opinion on investigational drugs.

Alternative Donor Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission: a CIBMTR-Eurocord Analysis

E. Gluckman, V. Rocha, X. Zhong, 2014 .

Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.

Alan M. Miller, M. Norkin, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR® study

E. Guinan, M. Boeckh, M. Aljurf, 2016, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation in systemic mastocytosis: is there a high risk for veno‐occlusive disease?

P. Valent, S. Devine, D. Weisdorf, 2016, European journal of haematology.

Heat Shock Protein 90 Inhibition Depletes TrkA Levels and Signaling in Human Acute Leukemia Cells

K. Bhalla, G. Reuther, R. Balusu, 2010, Molecular Cancer Therapeutics.

Molecular Cancer apeutics apeutic Discovery t Shock Protein 90 Inhibition Depletes TrkA Levels and Ther aling in Human Acute Leukemia Cells

Rao, K. Bhalla, G. Reuther, 2010 .

Dasatinib induces complete cytogenetic response and loss of F359C in an imatinib resistant chronic myelocytic leukemia patient

M. Salama, C. Ustun, A. Jillella, 2009, American journal of hematology.

Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.

A. Khoruts, M. MacMillan, D. Weisdorf, 2019, JCI insight.

Treatment of a patient with end‐stage renal disease with Rituximab: Pharmacokinetic evaluation suggests Rituximab is not eliminated by hemodialysis

C. Ustun, A. Jillella, A. Kallab, 2002, American journal of hematology.

Rituximab Provides Durable Remission in a Patient with Refractory Aggressive Diffuse B-cell Lymphoma Failing Salvage Chemotherapy

C. Ustun, A. Jillella, A. Kallab, 2002, Leukemia & lymphoma.

Interaction of Sickle Cell Trait with Hereditary Spherocytosis: Splenic Infarcts and Sequestration

A. Kutlar, C. Ustun, F. Kutlar, 2002, Acta Haematologica.

Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation

J. Wagner, G. Vercellotti, M. Verneris, 2014, Bone Marrow Transplantation.

Final Results of the Chrysalis Trial: A First-in-Human Phase 1/2 Dose-Escalation, Dose-Expansion Study of Gilteritinib (ASP2215) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

R. Larson, G. Martinelli, J. Cortes, 2016 .

Transplantation provides superior survival high risk myeloid malignancies in older patients

C. Ustun, L. Burns, E. Warlick, 2022, Leukemia & lymphoma.

Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemia.

J. Wagner, M. Verneris, C. Ustun, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Decitabine as “bridge therapy” to a MUD transplant in relapsed AML postautologous stem cell transplantation

C. Ustun, D. DeRemer, A. Jillella, 2008, American journal of hematology.

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

B. Wood, C. Hourigan, M. Linden, 2017, Haematologica.

Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation.

Tallman, B. Sandmaier, M. Tallman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

OUTCOMES OF UCB TRANSPLANTATION ARE COMPARABLE IN FLT3+ AML: RESULTS OF CIBMTR, EUROCORD AND EBMT COLLABORATIVE ANALYSIS

F. Baron, B. Sandmaier, M. Labopin, 2016, Leukemia.

Plasmablastic lymphoma: Cytologic findings in 5 cases with unusual presentation

C. Ustun, P. Ramalingam, S. Kavuri, 2008, Cancer.

Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT

V. Bachanova, J. Froelich, C. Ustun, 2015, Bone Marrow Transplantation.

Systemic mastocytosis with associated clonal hematological non‐mast‐cell lineage disease: A case review

K. Bhalla, T. George, J. Gotlib, 2012, American journal of hematology.

Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis

J. Pulido, M. Najafi, D. Koozekanani, 2020, American journal of ophthalmology case reports.

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

L. Pagano, M. Perales, I. Yakoub-Agha, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The challenges of treating aspergillus abdominal aneurysm after hematopoietic cell transplant: Rapid voriconazole metabolizer

C. Ustun, R. Faizer, M. Birkenbach, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells.

Jeffrey S. Miller, J. Gotlib, D. Vallera, 2018, Blood advances.

Anaplastic mast cell sarcoma: a unique pathologic entity in mastocytosis

M. Linden, Z. Cayci, H. Horny, 2017, Leukemia & lymphoma.

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

M. Linden, M. Burke, J. Miller, 2013, Bone Marrow Transplantation.

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

M. Triggiani, A. Órfão, H. Kluin-Nelemans, 2014 .

Genomics of clonal evolution in a case of essential thrombocythemia

M. Linden, D. Weisdorf, A. Rashidi, 2018, Leukemia & lymphoma.

Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality.

D. Weisdorf, B. Blazar, T. DeFor, 2020, Blood advances.

Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation

M. Beksac, U. Şahin, C. Ustun, 2018, Annals of Hematology.

Evolution of clonal dynamics and differential response to targeted therapy in a case of systemic mastocytosis with associated myelodysplastic syndrome.

M. Linden, A. Nelson, Z. Sachs, 2020, Leukemia research.

Near-tetraploidy clone can evolve from a hyperdiploidy clone and cause resistance to lenalidomide and bortezomib in a multiple myeloma patient.

Ji Yuan, C. Ustun, A. Kulharya, 2010, Leukemia research.

Encapsulated relapsed FLT3+AML (myeloid sarcoma) and Hürthle cell adenoma presenting in composite: Unlikely partners

M. Linden, Z. Cayci, C. Ustun, 2016, American journal of hematology.

Eosinophilic Fasciitis after Allogeneic Stem Cell Transplantation: A Case Report and Review of the Literature

C. Ustun, George Ho, Jr, 2004, Leukemia & lymphoma.

Sarcoid-like Histiocytic Proliferations in Patients With Lymphoma Can Be FDG-avid Concerning for Refractory or Recurrent Disease.

M. Linden, Z. Cayci, B. Peterson, 2019, Clinical lymphoma, myeloma & leukemia.

Plasmablastic lymphoma with small lymphocytic lymphoma: Clinico-pathologic features, and review of the literature

C. Ustun, P. Ramalingam, Jennifer Jones-Crawford, 2008, Leukemia & lymphoma.

GVHD after HLA-matched sibling BMT or PBSCT: Comparison of North American Caucasian and Japanese Populations

Shahrukh, W. Wood, J. Kanda, 2016 .

Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis

R. Idilman, I. Idilman, C. Ustun, 2022, Blood advances.

Does high‐dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?

P. Valent, W. Sperr, D. Weisdorf, 2013, American journal of hematology.

Synergistic Pre-Clinical Activity of Combined Epigenetic Therapy with the Novel Histone Methyltransferase EZH2 Inhibitor 3-Deazaneplanocin and Histone Deacetylase Inhibitor Panobinostat against Human AML Cells.

K. Bhalla, V. Marquez, C. Ustun, 2008 .

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation.

J. Wagner, D. Weisdorf, M. Arora, 2019, Blood advances.

Acute Myelogenous Leukemia Patients Are at Low Risk for Invasive Fungal Infections after High-Dose Cytarabine Consolidations and Thus Do Not Require Prophylaxis

C. Ustun, D. DeRemer, A. Jillella, 2010, Acta Haematologica.

Severe dyspnoea in a patient with chronic myelogenous leukaemia on a tyrosine kinase inhibitor

C. Ustun, K. Amin, H. E. Dincer, 2015, Thorax.

What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?

C. Ustun, A. Jillella, 2004, Stem cells and development.

Transformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumab

M. Linden, T. Singleton, V. Bachanova, 2013, Leukemia & lymphoma.

Core‐binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure

C. Bloomfield, K. Mrózek, M. Perales, 2020, International journal of laboratory hematology.

Effectiveness of dasatinib in accelerated-phase chronic myeloid leukemia with p190 BCR-ABL1 and a second Philadelphia chromosome.

S. Yohe, C. Ustun, M. Dolan, 2014, Cancer genetics.

Response of complex immune‐mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemia

R. Bollag, N. Key, M. Reding, 2012, European journal of haematology.

Myeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant

J. Byun, Tochukwu M Okwuosa, C. Ustun, 2022, Bone Marrow Transplantation.

Results of a first-in-human, phase I/II trial of ASP2215, a selective, potent inhibitor of FLT3/Axl in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML).

R. Larson, J. Cortes, M. Levis, 2015 .

Age is no Barrier for Adults undergoing HCT for AML in CR1: Contemporary CIBMTR Analysis

C. Hourigan, S. Farag, V. Bhatt, 2022, Bone Marrow Transplantation.

Kahn JM, Brazauskas R, Tecca HR, et al. Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. Blood Adv. 2020;4(9):2084-2094.

M. Norkin, B. George, R. Gale, 2020, Blood advances.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis.

W. Wood, R. Sparapani, R. Gale, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Cell Transplant Related Toxicities and Mortality in Frail Recipients.

S. Bhatia, D. Weisdorf, M. Arora, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Selective Inhibition of FLT3 by Gilteritinib in Relapsed/Refractory Acute Myeloid Leukemia: a Multicenter, First-in-human, Open-label, Phase 1/2 Study

R. Larson, G. Martinelli, J. Cortes, 2017, The Lancet. Oncology.

Resistant Microascus cirrosus pneumonia can be treated with a combination of surgery, multiple anti-fungal agents and a growth factor

K. Marr, G. Huls, C. Ustun, 2006, Mycopathologia.

Fatal Aspergillus fumigatus and Candida glabrata infections with posaconazole prophylaxis after stem cell transplantation.

J. Steele, C. Ustun, J. Fisher, 2008, International journal of antimicrobial agents.

Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation

C. Ustun, H. Fain, A. Jillella, 2007, Bone Marrow Transplantation.

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR® analysis

Allen R. Chen, M. Boeckh, M. Aljurf, 2015, Bone Marrow Transplantation.

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia

O. Frankfurt, S. Kambhampati, H. Kantarjian, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BACTERIAL BLOOD STREAM INFECTIONS (BSI), PARTICULARLY POST-ENGRAFTMENT BSI, ARE ASSOCIATED WITH INCREASED MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

G. Papanicolaou, V. Brown, M. Aljurf, 2018, Bone Marrow Transplantation.

Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study

P. Hari, J. Wingard, R. Gale, 2019, Bone Marrow Transplantation.

Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?

D. Weisdorf, C. Ustun, Jo-Anne H. Young, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Difficult Balance Between Multidrug-Resistant Cytomegalovirus Infection and Graft-Versus-Host Disease in an Allogeneic Hematopoietic Stem Cell Transplant Recipient

G. Papanicolaou, N. Lurain, Y. Rhee, 2020 .

COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter

J. Mehta, M. Bishop, C. Ustun, 2020, Leukemia.

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.

J. Wagner, P. Westervelt, J. Dipersio, 2018, Blood.

Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.

D. V. van Thiel, R. Idilman, N. De Maria, 2003, Hepato-gastroenterology.

Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type.

M. Robin, D. Weisdorf, G. Socié, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Alan M. Miller, R. Vij, F. Baron, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML

M. Linden, M. Burke, J. Miller, 2013, Bone Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis Determined by Disease Risk Index.

D. Weisdorf, M. Arora, A. Rashidi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute splenic complications and implications of splenectomy in hemoglobin SC disease

A. Kutlar, L. Daitch, C. Ustun, 2009, European journal of haematology.

Cotreatment with Vorinostat Enhances Activity of MK-0457 (VX-680) against Acute and Chronic Myelogenous Leukemia Cells

Rekha Rao, Ravindra Kolhe, Rajeshree Joshi, 2008, Clinical Cancer Research.

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.

Huidong Shi, P. Atadja, K. Bhalla, 2009, Blood.

Graft Versus Host Disease: Beyond Classical HLA Matching - A Shift in Paradigm

Anish Laul, C. Ustun, S. Nathan, 2020 .

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

R. Vij, B. Sandmaier, M. Aljurf, 2019, Haematologica.

Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia.

C. Ustun, Celalettin Ustun, David L Deremer, 2008, Clinical therapeutics.

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.

R. Larson, S. Paolini, G. Martinelli, 2019, The New England journal of medicine.

Extramedullary blastic crisis in abdominal lymph nodes in a patient with chronic myelogenous leukemia on imatinib.

Z. Cayci, C. Ustun, C. Brunstein, 2012, Leukemia research.

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells.

P. Atadja, R. Levine, K. Bhalla, 2009, Blood.

Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time.

J. Wagner, D. Weisdorf, C. Ustun, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Emerging diagnostic and therapeutic approaches in core binding factor acute myeloid leukaemia

G. Marcucci, C. Ustun, 2015, Current opinion in hematology.

Spontaneous complete resolution of pneumomediastinum and pneumatosis intestinalis caused by acute GVHD

Z. Cayci, C. Ustun, P. Arndt, 2016, American journal of hematology.

Management of Hematologic Disease in Mastocytosis

C. Ustun, H. D. Yun, 2019 .

Tyrosine kinase inhibitors in the treatment of systemic mastocytosis.

C. Akin, C. Ustun, D. DeRemer, 2011, Leukemia research.

Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.

K. Bhalla, M. Heinrich, C. Corless, 2009, Leukemia research.

Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.

M. MacMillan, D. Weisdorf, C. Ustun, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

R. Porcher, M. Robin, P. Chevallier, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2018, Haematologica.

Necessity for treatment of steroid refractory severe GIT GVHD: patience of providers

D. Weisdorf, A. Rashidi, C. Ustun, 2019, Bone Marrow Transplantation.

Association of breast cancer and immune thrombocytopenic purpura.

C. Bruker, C. Ustun, P. Dainer, 2002, Southern medical journal.

Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources.

W. Wood, M. Aljurf, K. Ballen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diabetes insipidus in myelodysplastic syndrome: what we learnt from a case regarding its diagnosis, pathophysiology and management

Z. Cayci, Charles Chuang, C. Ustun, 2015, Leukemia & lymphoma.

Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia.

M. Linden, D. Weisdorf, N. Bejanyan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

M. Norkin, M. Boeckh, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

J. Cortes, M. Aljurf, M. Tallman, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

G. Nilsson, M. Triggiani, A. Órfão, 2021, HemaSphere.

Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.

J. Cortes, M. Aljurf, J. Szer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.

E. Guinan, M. Aljurf, M. Pasquini, 2020, Biology of Blood and Marrow Transplantation.

with TBI following cyclophosphamide in combination with busulfan compared Better leukemia-free and overall survival in AML in first remission

J. Cortes, M. Aljurf, J. Szer, 2013 .

Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

K. Dusenbery, D. Weisdorf, M. Verneris, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

C. Bloomfield, R. Larson, K. Mrózek, 2019, Leukemia.

Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation.

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation

M. Linden, A. Rashidi, J. Miller, 2018, Bone Marrow Transplantation.

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD

J. Wagner, D. Weisdorf, M. Verneris, 2016, Haematologica.

Impact of Frailty on Hematopoietic Cell on Early Transplant Outcomes in Older Recipients

S. Bhatia, D. Weisdorf, M. Arora, 2015 .

Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations.

W. Wood, J. Kanda, Y. Kanda, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is Haploidentical HCT Better Than….? A Wrong Question for Future Studies.

C. Ustun, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Calcineurin-inhibitor induced pain syndrome after stem cell transplant

L. Muffly, C. Ustun, S. Nathan, 2020, Leukemia & lymphoma.

Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplant

J. Wagner, M. MacMillan, D. Weisdorf, 2014, Leukemia & lymphoma.

Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

K. Dusenbery, G. Vercellotti, Jeffrey S. Miller, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection.

A. Kutlar, C. Ustun, A. Jillella, 2003, Journal of hematotherapy & stem cell research.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

J Wagner, F. Awan, M. Krem, 2022, Transplantation and cellular therapy.

Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.

D. Weisdorf, T. DeFor, Z. Sachs, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease‐negative first complete remission

Kiran R. Vij, M. Linden, D. Weisdorf, 2018, American journal of hematology.

History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease‐negative first complete remission

M. Linden, D. Weisdorf, A. Rashidi, 2017, American journal of hematology.

C. Ustun, P. Fitzpatrick, S. Nathan, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Second allo-SCT from a different donor can improve severe steroid-resistant gut GVHD

F. Awan, J. Gossage, P. Martin, 2010, Bone Marrow Transplantation.

Chronic Myeloid Leukemia

K. Bhalla, C. Ustun, W. Fiskus, 2012 .

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

H. Kluin-Nelemans, S. Verstovsek, T. George, 2016, Haematologica.

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

H. Deeg, M. Perales, H. Kluin-Nelemans, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Use of sorafenib for post-transplant relapse in FLT3/ITD-positive acute myelogenous leukemia: maturation induction and cytotoxic effect

Z. Sachs, C. Ustun, Jessica J. Liegel, 2014, Haematologica.

R. Porcher, M. Robin, P. Chevallier, 2012 .

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.

R. Vij, M. Aljurf, R. Gale, 2022, JAMA oncology.

Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.

M. Aljurf, J. Szer, M. Tallman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1.

G. Papanicolaou, V. Brown, M. Perales, 2019, Blood advances.

Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study

P. Hari, V. Brown, H. Heslop, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival

M. Reding, D. Weisdorf, M. Reding, 2015, Bone Marrow Transplantation.

Weight‐based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation

J. Wagner, M. MacMillan, D. Weisdorf, 2018 .

Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

M. Aljurf, J. Szer, R. Gale, 2020 .

G. Vercellotti, M. Arora, V. Bachanova, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation in morphologic leukemia‐free aplastic state

P. Westervelt, J. Dipersio, Kiran R. Vij, 2017, American journal of hematology.

New Models of Therapy: When Acute Leukemia Becomes Chronic.

R. Stone, C. Ustun, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Significance of isolated deletion (20q) in donor cells after allogeneic hematopoietic cell transplantation

P. Venugopal, C. Ustun, S. Nathan, 2020, Leukemia & lymphoma.

Time-to-Event Ratio to Predict Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation?

Jeffrey S. Miller, S. Devine, D. Weisdorf, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lack of Clustering of SCD Complications Into Two Distinct Subphenotypes In An Adult Patient Population.

Hongyan Xu, A. Kutlar, C. Ustun, 2010 .

Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study.

G. Papanicolaou, K. Komanduri, K. Ahn, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemia

D. Weisdorf, A. Rashidi, N. Bejanyan, 2018, Leukemia & lymphoma.

To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century

H. Lazarus, C. Ustun, D. Weisdorf, 2013, Bone Marrow Transplantation.

Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.

C. Ustun, S. Nathan, A. Varma, 2022, Transplant immunology.

Human herpesvirus 6 is associated with status epilepticus and hyponatremia after umbilical cord blood transplantation

V. Bachanova, Z. Cayci, C. Ustun, 2014, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

DLBCL After Allogeneic HCT in a Patient With Transformed DLBCL: Does It Matter Whether Relapse or PTLD?

C. Ustun, M. J. Hussain, S. Nathan, 2019, Clinical lymphoma, myeloma & leukemia.

MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes

N. Bejanyan, C. Ustun, C. Brunstein, 2016, Bone Marrow Transplantation.

Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome

D. Weisdorf, T. DeFor, Z. Sachs, 2016, Bone Marrow Transplantation.

Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients

D. Weisdorf, M. Arora, V. Bachanova, 2014, American journal of hematology.

Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study.

M. Aljurf, J. Szer, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor.

J. Wagner, Chi Chen, G. Vercellotti, 2020, Blood advances.

Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers

C. Ustun, L. Mau, E. Denzen, 2019, Journal of Cancer Education.

Patients With a History of Chemotherapy and Isolated del(20q) With Minimal Myelodysplasia Have an Indolent Course.

M. Linden, S. Yohe, C. Ustun, 2016, American journal of clinical pathology.

The impact of donor type on outcomes and cost of allogeneic hematopoietic cell transplant for pediatric leukemia: a merged CIBMTR and PHIS analysis: Pediatric acute leukemia transplant risks and utilization.

W. Wood, D. Rizzieri, H. Lazarus, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gold is gold even in mud: NPM1 mutations in T-AML.

C. Ustun, 2023, Blood.

Anti-leukemia activity of histone deacetylase (HDAC) inhibitor LBH589 involves depletion of EZH2 and DNA methyltransferase (DNMT) 1 through disruption of their chaperone association with heat shock protein (hsp) 90

P. Atadja, K. Bhalla, C. Ustun, 2007 .

A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML.

O. Frankfurt, F. Ravandi, J. Pagel, 2018 .

Erythroid differentiation of myeloblast induced by gilteritinib in relapsed FLT3-ITD-positive acute myeloid leukemia.

C. Ustun, M. J. Hussain, S. Nathan, 2019, Blood advances.

How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?

W. Wood, Bryce Waldman, Z. DeFilipp, 2023, Blood reviews.

Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-Versus-Host Disease.

M. MacMillan, D. Weisdorf, B. Blazar, 2023, Transplantation and cellular therapy.

Abstract CT184: Gilteritinib significantly prolongs overall survival in patients withFLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): Results from the Phase III ADMIRAL trial

R. Larson, S. Paolini, G. Martinelli, 2019, Clinical Trials.

The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant—a CIBMTR study

M. Perales, H. Lazarus, C. Dandoy, 2022, Bone Marrow Transplantation.

Process of allogeneic hematopoietic cell transplantation decision making for older adults

K. Keven, C. Ustun, T. Atlı, 2016, Bone Marrow Transplantation.

Preliminary Safety and Efficacy from Apex, a Phase 2 Study of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Adults with Advanced Systemic Mastocytosis (AdvSM)

T. Tashi, C. Ustun, V. Pullarkat, 2022, Blood.

Proposed ECNM-AIM Response Criteria in Advanced Systemic Mastocytosis.

M. Triggiani, A. Órfão, J. Lyons, 2022, The journal of allergy and clinical immunology. In practice.

Concomitant cutaneous squamous cell carcinoma and chronic lymphocytic leukemia in a patient: The utility of 18F‐FDG PET/CT in differentiation of nodal metastasis

Z. Cayci, Matt Rischall, K. Ozturk, 2018, American journal of hematology.

A Serious Complication of Allogeneic Stem Cell Transplantation: Relapsing Pseudomonas aeruginosa Panniculitis

C. Ustun, D. DeRemer, A. Jillella, 2007 .

Lethal small bowel necrosis due to aspergillosis during acute promyelocytic leukemia induction

M. Linden, Z. Cayci, Charles Chuang, 2013, American journal of hematology.

Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia

Jeffrey S. Miller, J. Gotlib, D. Weisdorf, 2017, American journal of hematology.

Cancer Management and Research Dovepress Critical Appraisal of Nilotinib in Frontline Treatment of Chronic Myeloid Leukemia

C. Ustun, D. DeRemer, Katerina Katsanevas, 2022 .

Recurrence of Clostridium difficile infection after total colectomy in an allogeneic stem cell transplant patient

C. Ustun, Jo-Anne H. Young, L. B. Kreuziger, 2012, Bone Marrow Transplantation.

Breaking the Age Barrier: Physicians' Perceptions on Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults.

W. Wood, M. Sorror, D. Howard, 2021, Transplantation and cellular therapy.

Avapritinib versus Placebo in Indolent Systemic Mastocytosis

M. Triggiani, I. Dybedal, T. Tashi, 2023, NEJM Evidence.

Near-tetraploidy clone can evolve from a hyperdiploidy clone and cause resistance to lenalidomide and bortezomib in a multiple myeloma patient.

Ji Yuan, C. Ustun, A. Kulharya, 2010, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.

Huidong Shi, P. Atadja, K. Bhalla, 2009, Blood.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts

W. Sperr, W. Rabitsch, Daniel Ivanov, 2023, International journal of molecular sciences.

Cryptococcal meningitis following autologous stem cell transplantation in a patient with multiple myeloma

C. Ustun, A. Jillella, A. Kallab, 2002, Bone Marrow Transplantation.

Acute Myelogenous Leukemia Patients Are at Low Risk for Invasive Fungal Infections after High-Dose Cytarabine Consolidations and Thus Do Not Require Prophylaxis

C. Ustun, D. DeRemer, A. Jillella, 2010, Acta Haematologica.

Transformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumab

M. Linden, T. Singleton, V. Bachanova, 2013, Leukemia & lymphoma.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

U. Popat, M. Kalaycio, Z. DeFilipp, 2018, Blood advances.

Post-transplantation cyclophosphamide is associated with increased bacterial infections.

G. Papanicolaou, M. Perales, C. Dandoy, 2023, Bone marrow transplantation.

A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.

M. Beksac, C. Ustun, T. Ozcelik, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

B. Sandmaier, M. Aljurf, M. Grunwald, 2019, Haematologica.

Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User´s Guide for Daily Clinical Practice.

M. Triggiani, A. Órfão, T. George, 2022, The journal of allergy and clinical immunology. In practice.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

M. Norkin, R. Vij, W. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers

C. Ustun, L. Mau, L. Burns, 2019, Journal of Cancer Education.

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

C. Ustun, D. DeRemer, Katerina Katsanevas, 2011 .